Understanding APAC’s LDT regulations – A Strategic Outlook for Healthcare Companies

Laboratory-Developed Tests (LDTs) play a critical role in addressing unmet medical needs, yet the APAC region faces a fragmented regulatory landscape that challenges market access, patient safety, and diagnostic reliability. 

We collaborated with regulatory experts and industry leaders to develop our latest whitepaper, “𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗟𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲 𝗼𝗳 𝗟𝗮𝗯𝗼𝗿𝗮𝘁𝗼𝗿𝘆-𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗲𝗱 𝗧𝗲𝘀𝘁𝘀 (𝗟𝗗𝗧𝘀) 𝗶𝗻 𝗔𝗣𝗔𝗖,” which provides a comprehensive review of the region’s regulatory environment. 

Join us for a webinar to uncover the landscape and insights of the paper.  

Exclusively for APACMed Members. For enquiries, please contact info@apacmed.org.